Background: Heparin-induced thrombocytopenia is caused by antibody formation to heparin-
platelet factor 4 complexes. It typically develops 5 to 14 days after the initiation of heparin …

Preview Heparin, one of the most widely used drugs in the hospital setting, carries the risk of
thrombocytopenia. Fortunately, the condition is usually mild and reversible. However, if …

Objectives: Describe the clinical presentation of heparin-induced thrombocytopenia. Explain
the potential complications of heparin-induced thrombocytopenia. Review the …

PURPOSE: The complications of heparin-induced thrombocytopenia include thrombosis
and death. The purpose of the study was to determine whether early heparin cessation can …

Heparin-induced thrombocytopenia and associated thrombotic events, relatively common
side effects of heparin therapy, can cause substantial morbidity and mortality. Typically …

Although adverse reactions to heparin are rare and usually quickly reversible, recent shidies
have reported a potentially more serious complication occurring in up to SO percent of …

Background: Heparin-induced thrombocytopenia is a prothrombotic drug reaction caused by
platelet-activating antibodies that recognize complexes of platelet factor 4 and heparin …

Thrombocytopenia is a lesser known but significant complication of heparin therapy.
Heparin-dependent, antibody-mediated thrombocytopenia may be accompanied by …

Background Heparin-induced thrombocytopenia is a relatively common antibody-mediated
drug reaction. We studied the temporal relation between previous or current heparin therapy …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated disorder caused by the
development of antibodies to platelet factor 4 (PF4) and heparin. The thrombocytopenia is …